Condition
Skin Disorder
Total Trials
5
Recruiting
1
Active
1
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
25%
1 of 4 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (4)
Early P 1 (1)
Trial Status
Completed4
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07213154Not ApplicableRecruiting
Optical Imaging Scans for the Diagnosis of Skin Cancer in Patients With Lesions
NCT05127044Not ApplicableCompletedPrimary
Characterization of Pre-Term Neonatal Skin
NCT05506644Not ApplicableCompleted
Biofeedback for Psoriasis
NCT05287724Early Phase 1Completed
Defining N-Acetyl Cysteine as a Treatment for Inhibiting Prurogenic Stimuli
NCT04834167Not ApplicableCompleted
OneDoc Picopulse™ for the Treatment of Melasma Among Malaysian Women
Showing all 5 trials